KPV mastery course
Unit 6 of 11
IBD & colitis applications
Inflammatory bowel disease is where KPV's evidence is deepest. Across multiple mouse colitis models and several labs, o…
The strongest case for KPV, and its honest ceiling
Inflammatory bowel disease is where KPV's evidence is deepest. Across multiple mouse colitis models and several labs, oral KPV reduced disease activity, lowered cytokines, and improved tissue histology. The mechanism (PepT1 uptake plus NF-κB suppression) and the results line up into a coherent story.
This unit lays out that preclinical case fairly, and then draws the line clearly: reproducible mouse data is real and encouraging, but there is no large human trial and no approved KPV product for IBD.